Posted by Michael Wonder on 06 Jul 2026
More people to access cholesterol lowering medicine
30 June 2026 - PHARMAC will widen access to rosuvastatin, a medicine used to treat high cholesterol and reduce the risk of heart attack and stroke, following its 2025/26 Annual Tender process.
Rosuvastatin tablets will be available without restrictions from 1 October 2026. This means people will no longer need to meet specific eligibility criteria to access the medicine.
